MAP2K2

UniProt ID: P36507
Organism: Homo sapiens
Review Status: IN PROGRESS
πŸ“ Provide Detailed Feedback

Gene Description

MAP2K2 (MEK2) is a dual-specificity protein kinase in the RAF–MEK–ERK signaling cascade. It phosphorylates the activation-loop threonine and tyrosine residues of ERK MAP kinases, linking upstream signaling to changes in cellular proliferation and differentiation.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0000165 MAPK cascade
IBA
GO_REF:0000033
ACCEPT
Summary: MAP2K2 is the MEK2 kinase in the RAF–MEK–ERK cascade.
Reason: MAP2K2 is the MEK2 kinase in the RAF–MEK–ERK cascade.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0004672 protein kinase activity
IEA
GO_REF:0000002
MODIFY
Summary: MAP kinase kinase activity specifies the conserved MEK2 substrate class.
Reason: MAP kinase kinase activity specifies the conserved MEK2 substrate class.
Proposed replacements: MAP kinase kinase activity
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0004674 protein serine/threonine kinase activity
TAS
Reactome:R-HSA-109862
MODIFY
Summary: MEK2 phosphorylates both threonine and tyrosine in ERK activation loops; MAP kinase kinase activity is the informative function.
Reason: MEK2 phosphorylates both threonine and tyrosine in ERK activation loops; MAP kinase kinase activity is the informative function.
Proposed replacements: MAP kinase kinase activity
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0004708 MAP kinase kinase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Recombinant human MEK2 phosphorylated ERK1 on threonine and tyrosine and activated its kinase activity over100-fold.
Supporting Evidence:
PMID:8388392
Both MEK1 and MEK2 were expressed in Escherichia coli and shown to be able to activate recombinant human ERK1 in vitro. The purified MEK2 protein stimulated threonine and tyrosine phosphorylation on ERK1 and concomitantly activated ERK1 kinase activity more than 100-fold.
GO:0004708 MAP kinase kinase activity
IDA
PMID:8388392
Cloning and characterization of two distinct human extracell...
ACCEPT
Summary: Recombinant human MEK2 phosphorylated ERK1 on threonine and tyrosine and activated its kinase activity over100-fold.
Supporting Evidence:
PMID:8388392
Both MEK1 and MEK2 were expressed in Escherichia coli and shown to be able to activate recombinant human ERK1 in vitro. The purified MEK2 protein stimulated threonine and tyrosine phosphorylation on ERK1 and concomitantly activated ERK1 kinase activity more than 100-fold.
GO:0004708 MAP kinase kinase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Recombinant human MEK2 phosphorylated ERK1 on threonine and tyrosine and activated its kinase activity over100-fold.
Supporting Evidence:
PMID:8388392
Both MEK1 and MEK2 were expressed in Escherichia coli and shown to be able to activate recombinant human ERK1 in vitro. The purified MEK2 protein stimulated threonine and tyrosine phosphorylation on ERK1 and concomitantly activated ERK1 kinase activity more than 100-fold.
GO:0004712 protein serine/threonine/tyrosine kinase activity
TAS
PMID:19565474
The ERK signaling cascade--views from different subcellular ...
ACCEPT
Summary: Recombinant human MEK2 phosphorylated ERK1 on threonine and tyrosine and activated its kinase activity over100-fold.
Supporting Evidence:
PMID:8388392
Both MEK1 and MEK2 were expressed in Escherichia coli and shown to be able to activate recombinant human ERK1 in vitro. The purified MEK2 protein stimulated threonine and tyrosine phosphorylation on ERK1 and concomitantly activated ERK1 kinase activity more than 100-fold.
GO:0004713 protein tyrosine kinase activity
EXP
PMID:10409742
Kinase suppressor of Ras forms a multiprotein signaling comp...
MODIFY
Summary: The established substrate class is MAP kinases; MAP kinase kinase activity describes the dual-specificity reaction more informatively.
Reason: The established substrate class is MAP kinases; MAP kinase kinase activity describes the dual-specificity reaction more informatively.
Proposed replacements: MAP kinase kinase activity
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0004713 protein tyrosine kinase activity
IEA
GO_REF:0000116
MODIFY
Summary: The established substrate class is MAP kinases; MAP kinase kinase activity describes the dual-specificity reaction more informatively.
Reason: The established substrate class is MAP kinases; MAP kinase kinase activity describes the dual-specificity reaction more informatively.
Proposed replacements: MAP kinase kinase activity
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005078 MAP kinase scaffold activity
IEA
GO_REF:0000117
UNDECIDED
Summary: MAP2K2 can interact with KSR-family scaffolds, but binding a scaffold does not itself establish MAP kinase scaffold activity. The specific source-side mechanism requires verification.
Reason: MAP2K2 can interact with KSR-family scaffolds, but binding a scaffold does not itself establish MAP kinase scaffold activity. The specific source-side mechanism requires verification.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005078 MAP kinase scaffold activity
IMP
PMID:29433126
MEK drives BRAF activation through allosteric control of KSR...
UNDECIDED
Summary: MAP2K2 can interact with KSR-family scaffolds, but binding a scaffold does not itself establish MAP kinase scaffold activity. The specific source-side mechanism requires verification.
Reason: MAP2K2 can interact with KSR-family scaffolds, but binding a scaffold does not itself establish MAP kinase scaffold activity. The specific source-side mechanism requires verification.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:11909642
Identification of interaction between MEK2 and A-Raf-1.
UNDECIDED
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions. The target-specific support in PMID:11909642 still requires detailed assessment of the experimental results.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions. The target-specific support in PMID:11909642 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:11909642
Identification of interaction between MEK2 and A-Raf-1.
UNDECIDED
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions. The target-specific support in PMID:11909642 still requires detailed assessment of the experimental results.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions. The target-specific support in PMID:11909642 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:11909642
Identification of interaction between MEK2 and A-Raf-1.
UNDECIDED
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions. The target-specific support in PMID:11909642 still requires detailed assessment of the experimental results.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions. The target-specific support in PMID:11909642 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:17979178
A novel tandem affinity purification strategy for the effici...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:21615688
Identification of mitogen-activated protein/extracellular si...
UNDECIDED
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:21988832
Toward an understanding of the protein interaction network o...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:21988832
Toward an understanding of the protein interaction network o...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:24746704
Disruption of CRAF-mediated MEK activation is required for e...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:24746704
Disruption of CRAF-mediated MEK activation is required for e...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:24746704
Disruption of CRAF-mediated MEK activation is required for e...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:25600339
Tunable-combinatorial mechanisms of acquired resistance limi...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:25852190
Integrative analysis of kinase networks in TRAIL-induced apo...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:27086506
HiQuant: Rapid Postquantification Analysis of Large-Scale MS...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:29433126
MEK drives BRAF activation through allosteric control of KSR...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:29433126
MEK drives BRAF activation through allosteric control of KSR...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:31980649
Extensive rewiring of the EGFR network in colorectal cancer ...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:31980649
Extensive rewiring of the EGFR network in colorectal cancer ...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:31980649
Extensive rewiring of the EGFR network in colorectal cancer ...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:31980649
Extensive rewiring of the EGFR network in colorectal cancer ...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:32707033
Kinase Interaction Network Expands Functional and Disease Ro...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:32707033
Kinase Interaction Network Expands Functional and Disease Ro...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:32707033
Kinase Interaction Network Expands Functional and Disease Ro...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:32707033
Kinase Interaction Network Expands Functional and Disease Ro...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:32814053
Interactome Mapping Provides a Network of Neurodegenerative ...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:35271311
OpenCell: Endogenous tagging for the cartography of human ce...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:35271311
OpenCell: Endogenous tagging for the cartography of human ce...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:35271311
OpenCell: Endogenous tagging for the cartography of human ce...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:35512704
Systematic discovery of mutation-directed neo-protein-protei...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005515 protein binding
IPI
PMID:36115835
Quantitative fragmentomics allow affinity mapping of interac...
KEEP AS NON CORE
Summary: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Reason: The observed protein interaction is retained but generic protein binding does not distinguish catalytic signaling from other interactions.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005524 ATP binding
IEA
GO_REF:0000002
ACCEPT
Summary: ATP is the phosphate donor for the conserved MAP2K2 reaction.
Reason: ATP is the phosphate donor for the conserved MAP2K2 reaction.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005576 extracellular region
NAS
PMID:8388392
Cloning and characterization of two distinct human extracell...
UNDECIDED
Summary: An extracellular localization is not explained by the intracellular MEK2 kinase mechanism. The source experiment has not been evaluated at the assay level here, so the assignment is not rejected solely from localization expectations. The target-specific support in PMID:8388392 still requires detailed assessment of the experimental results.
Reason: An extracellular localization is not explained by the intracellular MEK2 kinase mechanism. The source experiment has not been evaluated at the assay level here, so the assignment is not rejected solely from localization expectations. The target-specific support in PMID:8388392 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005634 nucleus
TAS
PMID:19565474
The ERK signaling cascade--views from different subcellular ...
KEEP AS NON CORE
Summary: ERK-pathway proteins can redistribute across compartments; a nuclear pool is compatible with signaling but is not the defining MEK2 location.
Reason: ERK-pathway proteins can redistribute across compartments; a nuclear pool is compatible with signaling but is not the defining MEK2 location.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005737 cytoplasm
EXP
PMID:10409742
Kinase suppressor of Ras forms a multiprotein signaling comp...
ACCEPT
Summary: MEK2 is an intracellular kinase in cytoplasmic RAF–MEK–ERK signaling complexes.
Reason: MEK2 is an intracellular kinase in cytoplasmic RAF–MEK–ERK signaling complexes.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005737 cytoplasm
IEA
GO_REF:0000044
ACCEPT
Summary: MEK2 is an intracellular kinase in cytoplasmic RAF–MEK–ERK signaling complexes.
Reason: MEK2 is an intracellular kinase in cytoplasmic RAF–MEK–ERK signaling complexes.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005739 mitochondrion
IEA
GO_REF:0000117
UNDECIDED
Summary: Mitochondrial localization needs compartment-specific evidence beyond conservation of kinase activity.
Reason: Mitochondrial localization needs compartment-specific evidence beyond conservation of kinase activity.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005739 mitochondrion
TAS
PMID:19565474
The ERK signaling cascade--views from different subcellular ...
UNDECIDED
Summary: Mitochondrial localization needs compartment-specific evidence beyond conservation of kinase activity.
Reason: Mitochondrial localization needs compartment-specific evidence beyond conservation of kinase activity.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005769 early endosome
IEA
GO_REF:0000117
UNDECIDED
Summary: An early-endosome pool is context-specific and cannot be resolved from the conserved kinase sequence alone.
Reason: An early-endosome pool is context-specific and cannot be resolved from the conserved kinase sequence alone.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005769 early endosome
TAS
PMID:19565474
The ERK signaling cascade--views from different subcellular ...
UNDECIDED
Summary: An early-endosome pool is context-specific and cannot be resolved from the conserved kinase sequence alone.
Reason: An early-endosome pool is context-specific and cannot be resolved from the conserved kinase sequence alone.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005770 late endosome
IEA
GO_REF:0000117
UNDECIDED
Summary: A late-endosome pool requires localization evidence; the core MEK2 reaction does not establish it.
Reason: A late-endosome pool requires localization evidence; the core MEK2 reaction does not establish it.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005770 late endosome
TAS
PMID:19565474
The ERK signaling cascade--views from different subcellular ...
UNDECIDED
Summary: A late-endosome pool requires localization evidence; the core MEK2 reaction does not establish it.
Reason: A late-endosome pool requires localization evidence; the core MEK2 reaction does not establish it.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005778 peroxisomal membrane
HDA
PMID:21525035
PEX14 is required for microtubule-based peroxisome motility ...
UNDECIDED
Summary: The available PEX14-study abstract does not resolve MEK2-specific peroxisomal membrane association. The full proteomic/experimental material is needed; a different gene in the title is not grounds for removal.
Reason: The available PEX14-study abstract does not resolve MEK2-specific peroxisomal membrane association. The full proteomic/experimental material is needed; a different gene in the title is not grounds for removal.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005783 endoplasmic reticulum
IDA
PMID:21615688
Identification of mitogen-activated protein/extracellular si...
UNDECIDED
Summary: The specific ER localization requires the original experimental evidence, whose specific experimental results remain to be assessed. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Reason: The specific ER localization requires the original experimental evidence, whose specific experimental results remain to be assessed. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005794 Golgi apparatus
IDA
PMID:21615688
Identification of mitogen-activated protein/extracellular si...
UNDECIDED
Summary: The specific Golgi localization requires the original experimental localization data, rather than transfer from broad ERK-pathway biology. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Reason: The specific Golgi localization requires the original experimental localization data, rather than transfer from broad ERK-pathway biology. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005794 Golgi apparatus
TAS
PMID:19565474
The ERK signaling cascade--views from different subcellular ...
UNDECIDED
Summary: The specific Golgi localization requires the original experimental localization data, rather than transfer from broad ERK-pathway biology.
Reason: The specific Golgi localization requires the original experimental localization data, rather than transfer from broad ERK-pathway biology.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
IDA
GO_REF:0000052
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
PMID:19565474
The ERK signaling cascade--views from different subcellular ...
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-109858
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-109862
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-109864
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-5211356
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-5672972
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-5672973
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-5672978
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-5672980
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-5674130
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-5674132
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-5674366
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-5674373
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-5674496
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802910
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802911
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802912
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802914
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802918
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802919
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802921
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802922
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802925
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802926
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802932
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802933
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802934
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802935
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802942
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6802943
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6803227
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6803230
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6803233
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6803234
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9610152
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9610153
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9610154
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9610156
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9652165
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9656209
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9656211
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9656214
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9656215
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9657599
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9657603
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9657606
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9657608
ACCEPT
Summary: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Reason: Cytosolic MEK2 is consistent with the characterized intracellular MAPK signaling complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0005874 microtubule
IDA
PMID:21615688
Identification of mitogen-activated protein/extracellular si...
UNDECIDED
Summary: The specific microtubule association requires the original localization/interaction evidence, whose target-specific results require assessment. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Reason: The specific microtubule association requires the original localization/interaction evidence, whose target-specific results require assessment. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005911 cell-cell junction
IDA
PMID:21615688
Identification of mitogen-activated protein/extracellular si...
UNDECIDED
Summary: Cell-junction localization is a specific spatial claim not established by core kinase activity. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Reason: Cell-junction localization is a specific spatial claim not established by core kinase activity. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005925 focal adhesion
IEA
GO_REF:0000117
UNDECIDED
Summary: Focal-adhesion localization requires a distinct cellular experiment or grounded transfer of that observation.
Reason: Focal-adhesion localization requires a distinct cellular experiment or grounded transfer of that observation.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0005925 focal adhesion
TAS
PMID:19565474
The ERK signaling cascade--views from different subcellular ...
UNDECIDED
Summary: Focal-adhesion localization requires a distinct cellular experiment or grounded transfer of that observation.
Reason: Focal-adhesion localization requires a distinct cellular experiment or grounded transfer of that observation.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0009898 cytoplasmic side of plasma membrane
IDA
PMID:21615688
Identification of mitogen-activated protein/extracellular si...
UNDECIDED
Summary: KSR–MEK association recruits MEK into membrane-associated fractions on the cytoplasmic side of the signaling membrane. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Reason: KSR–MEK association recruits MEK into membrane-associated fractions on the cytoplasmic side of the signaling membrane. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0010628 positive regulation of gene expression
IMP
PMID:24375836
MiR-92a mediates AZD6244 induced apoptosis and G1-phase arre...
UNDECIDED
Summary: The gene-expression response is stimulus- and assay-dependent; the original experimental reference requires closer evaluation. The target-specific support in PMID:24375836 still requires detailed assessment of the experimental results.
Reason: The gene-expression response is stimulus- and assay-dependent; the original experimental reference requires closer evaluation. The target-specific support in PMID:24375836 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0016020 membrane
EXP
PMID:10409742
Kinase suppressor of Ras forms a multiprotein signaling comp...
ACCEPT
Summary: The KSR interaction study detects MEK in membrane-associated fractions, supporting membrane association without a transmembrane protein model.
Reason: The KSR interaction study detects MEK in membrane-associated fractions, supporting membrane association without a transmembrane protein model.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0016020 membrane
IEA
GO_REF:0000044
ACCEPT
Summary: The KSR interaction study detects MEK in membrane-associated fractions, supporting membrane association without a transmembrane protein model.
Reason: The KSR interaction study detects MEK in membrane-associated fractions, supporting membrane association without a transmembrane protein model.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0030165 PDZ domain binding
IDA
PMID:21615688
Identification of mitogen-activated protein/extracellular si...
UNDECIDED
Summary: PDZ-domain binding is a specific interaction claim requiring the original binding assay; a kinase-domain annotation does not establish it. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Reason: PDZ-domain binding is a specific interaction claim requiring the original binding assay; a kinase-domain annotation does not establish it. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0032872 regulation of stress-activated MAPK cascade
IEA
GO_REF:0000117
UNDECIDED
Summary: Participation in ERK signaling does not by itself establish regulation of a stress-activated MAPK cascade; pathway cross-talk requires evidence.
Reason: Participation in ERK signaling does not by itself establish regulation of a stress-activated MAPK cascade; pathway cross-talk requires evidence.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0032872 regulation of stress-activated MAPK cascade
TAS
PMID:19565474
The ERK signaling cascade--views from different subcellular ...
UNDECIDED
Summary: Participation in ERK signaling does not by itself establish regulation of a stress-activated MAPK cascade; pathway cross-talk requires evidence.
Reason: Participation in ERK signaling does not by itself establish regulation of a stress-activated MAPK cascade; pathway cross-talk requires evidence.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0036289 peptidyl-serine autophosphorylation
IDA
PMID:8388392
Cloning and characterization of two distinct human extracell...
UNDECIDED
Summary: MEK2 catalytic activity does not by itself prove serine autophosphorylation. The missing primary experiment is needed to distinguish auto- from trans-phosphorylation. The target-specific support in PMID:8388392 still requires detailed assessment of the experimental results.
Reason: MEK2 catalytic activity does not by itself prove serine autophosphorylation. The missing primary experiment is needed to distinguish auto- from trans-phosphorylation. The target-specific support in PMID:8388392 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0043539 protein serine/threonine kinase activator activity
IDA
PMID:8388392
Cloning and characterization of two distinct human extracell...
ACCEPT
Summary: Recombinant human MEK2 phosphorylated ERK1 on threonine and tyrosine and activated its kinase activity over100-fold.
Supporting Evidence:
PMID:8388392
Both MEK1 and MEK2 were expressed in Escherichia coli and shown to be able to activate recombinant human ERK1 in vitro. The purified MEK2 protein stimulated threonine and tyrosine phosphorylation on ERK1 and concomitantly activated ERK1 kinase activity more than 100-fold.
GO:0043539 protein serine/threonine kinase activator activity
IEA
GO_REF:0000117
ACCEPT
Summary: Recombinant human MEK2 phosphorylated ERK1 on threonine and tyrosine and activated its kinase activity over100-fold.
Supporting Evidence:
PMID:8388392
Both MEK1 and MEK2 were expressed in Escherichia coli and shown to be able to activate recombinant human ERK1 in vitro. The purified MEK2 protein stimulated threonine and tyrosine phosphorylation on ERK1 and concomitantly activated ERK1 kinase activity more than 100-fold.
GO:0045893 positive regulation of DNA-templated transcription
IMP
PMID:24375836
MiR-92a mediates AZD6244 induced apoptosis and G1-phase arre...
UNDECIDED
Summary: The original transcription-response study requires closer evaluation; generic ERK signaling alone does not establish this specific positive transcriptional response. The target-specific support in PMID:24375836 still requires detailed assessment of the experimental results.
Reason: The original transcription-response study requires closer evaluation; generic ERK signaling alone does not establish this specific positive transcriptional response. The target-specific support in PMID:24375836 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0048471 perinuclear region of cytoplasm
IDA
PMID:21615688
Identification of mitogen-activated protein/extracellular si...
UNDECIDED
Summary: The source-specific perinuclear localization requires the original imaging evidence. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Reason: The source-specific perinuclear localization requires the original imaging evidence. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10409742}. Membrane CC {ECO:0000269|PubMed:10409742}; Peripheral membrane protein CC {ECO:0000269|PubMed:10409742}. Note=Membrane localization is probably CC regulated by its interaction with KSR1. {ECO:0000269|PubMed:10409742}.
GO:0070371 ERK1 and ERK2 cascade
IMP
PMID:24375836
MiR-92a mediates AZD6244 induced apoptosis and G1-phase arre...
UNDECIDED
Summary: The ERK1/ERK2 cascade is the defining pathway for MEK2-mediated MAP kinase activation. The target-specific support in PMID:24375836 still requires detailed assessment of the experimental results.
Reason: The ERK1/ERK2 cascade is the defining pathway for MEK2-mediated MAP kinase activation. The target-specific support in PMID:24375836 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0070371 ERK1 and ERK2 cascade
TAS
Reactome:R-HSA-112411
ACCEPT
Summary: The ERK1/ERK2 cascade is the defining pathway for MEK2-mediated MAP kinase activation.
Reason: The ERK1/ERK2 cascade is the defining pathway for MEK2-mediated MAP kinase activation.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0071902 positive regulation of protein serine/threonine kinase activity
IDA
PMID:8388392
Cloning and characterization of two distinct human extracell...
ACCEPT
Summary: Recombinant human MEK2 phosphorylated ERK1 on threonine and tyrosine and activated its kinase activity over100-fold.
Supporting Evidence:
PMID:8388392
Both MEK1 and MEK2 were expressed in Escherichia coli and shown to be able to activate recombinant human ERK1 in vitro. The purified MEK2 protein stimulated threonine and tyrosine phosphorylation on ERK1 and concomitantly activated ERK1 kinase activity more than 100-fold.
GO:0090170 regulation of Golgi inheritance
IEA
GO_REF:0000117
UNDECIDED
Summary: The specific Golgi-inheritance role requires the relevant cell-cycle experiments.
Reason: The specific Golgi-inheritance role requires the relevant cell-cycle experiments.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0090170 regulation of Golgi inheritance
TAS
PMID:19565474
The ERK signaling cascade--views from different subcellular ...
UNDECIDED
Summary: The specific Golgi-inheritance role requires the relevant cell-cycle experiments.
Reason: The specific Golgi-inheritance role requires the relevant cell-cycle experiments.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0097110 scaffold protein binding
IEA
GO_REF:0000117
ACCEPT
Summary: The KSR interaction study demonstrates MEK association with a Ras–MAPK scaffolding complex.
Reason: The KSR interaction study demonstrates MEK association with a Ras–MAPK scaffolding complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0097110 scaffold protein binding
IPI
PMID:10409742
Kinase suppressor of Ras forms a multiprotein signaling comp...
ACCEPT
Summary: The KSR interaction study demonstrates MEK association with a Ras–MAPK scaffolding complex.
Reason: The KSR interaction study demonstrates MEK association with a Ras–MAPK scaffolding complex.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0097110 scaffold protein binding
IPI
PMID:21615688
Identification of mitogen-activated protein/extracellular si...
UNDECIDED
Summary: The KSR interaction study demonstrates MEK association with a Ras–MAPK scaffolding complex. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Reason: The KSR interaction study demonstrates MEK association with a Ras–MAPK scaffolding complex. The target-specific support in PMID:21615688 still requires detailed assessment of the experimental results.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0106310 protein serine kinase activity
EXP
PMID:10409742
Kinase suppressor of Ras forms a multiprotein signaling comp...
MODIFY
Summary: The conserved function is activation-loop phosphorylation of MAP kinases; use the substrate-class-specific MAP kinase kinase activity.
Reason: The conserved function is activation-loop phosphorylation of MAP kinases; use the substrate-class-specific MAP kinase kinase activity.
Proposed replacements: MAP kinase kinase activity
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:0106310 protein serine kinase activity
IEA
GO_REF:0000116
MODIFY
Summary: The conserved function is activation-loop phosphorylation of MAP kinases; use the substrate-class-specific MAP kinase kinase activity.
Reason: The conserved function is activation-loop phosphorylation of MAP kinases; use the substrate-class-specific MAP kinase kinase activity.
Proposed replacements: MAP kinase kinase activity
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:2000641 regulation of early endosome to late endosome transport
IEA
GO_REF:0000117
UNDECIDED
Summary: Regulation of early-to-late endosome transport is not established merely by the conserved MEK2 catalytic domain.
Reason: Regulation of early-to-late endosome transport is not established merely by the conserved MEK2 catalytic domain.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.
GO:2000641 regulation of early endosome to late endosome transport
TAS
PMID:19565474
The ERK signaling cascade--views from different subcellular ...
UNDECIDED
Summary: Regulation of early-to-late endosome transport is not established merely by the conserved MEK2 catalytic domain.
Reason: Regulation of early-to-late endosome transport is not established merely by the conserved MEK2 catalytic domain.
Supporting Evidence:
file:human/MAP2K2/MAP2K2-uniprot.txt
CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.

Core Functions

MAP2K2 (MEK2) is a dual-specificity protein kinase in the RAF–MEK–ERK signaling cascade. It phosphorylates the activation-loop threonine and tyrosine residues of ERK MAP kinases, linking upstream signaling to changes in cellular proliferation and differentiation.

Molecular Function:
MAP kinase kinase activity
Supporting Evidence:
  • file:human/MAP2K2/MAP2K2-uniprot.txt
    CC -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and CC a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. CC Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF CC in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases CC the inhibitory intramolecular interaction between KSR1 or KSR2 protein CC kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF CC dimerization and BRAF activation (PubMed:29433126). CC {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.

References

Loading supporting content…

Download this section (compressed HTML)

Deep Research

Falcon

(MAP2K2-deep-research-falcon.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(MAP2K2-notes.md)

MAP2K2: evidence notes

Paired horse benchmark evidence review

The human reference supplies mechanistic evidence for the corresponding selected horse protein; the human conclusion alone is not validation of the horse sequence. The exact horse comparison is in genes/HORSE/MAP2K2/MAP2K2-bioinformatics/RESULTS.md. Research reports are source leads; annotation decisions cite the underlying publication or experimentally supported UniProt passages. Unresolved source-specific results retain UNDECIDED.

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)